Abstract | PURPOSE: DESIGN: Retrospective, comparative case series. METHODS: This study retrospectively reviewed the medical records of 116 SJS/TEN patients who developed the disease between 2002 and 2018. Patients with severe ocular disorders (ie, ocular surface epithelial defect, pseudomembranous formation, or both) at the acute stage and who were followed for >1 year post SJS/TEN onset were enrolled. In those patients, the treatments administered for acute-stage SJS/TEN and associated ocular sequelae were examined, including the best-corrected visual acuity (BCVA) in the patient's worse eye and the incidence of the ocular complications at the final follow-up examination. RESULTS: A total of 85 patients were enrolled. Of those, 36 received CPT within 4 days post disease onset (group A) and 49 patients did not receive CPT within 4 days post disease onset (group B). The percentage of eyes with a BCVA in the worse eye of ≥ 1.0 were 52.8% in group A and 14.3% in group B. Severe ocular sequelae (ie, a worsening of BCVA and corneal and conjunctival complications) were significantly less in group A than in group B. CONCLUSIONS: In SJS/TEN patients with acute ocular involvement, CPT initiated within 4 days from disease onset may help reduce severe ocular sequelae.
|
Authors | Hiroki Mieno, Mayumi Ueta, Fumie Kinoshita, Satoshi Teramukai, Shigeru Kinoshita, Chie Sotozono |
Journal | American journal of ophthalmology
(Am J Ophthalmol)
Vol. 231
Pg. 194-199
(11 2021)
ISSN: 1879-1891 [Electronic] United States |
PMID | 34214456
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021. Published by Elsevier Inc. |
Chemical References |
|
Topics |
- Adrenal Cortex Hormones
- Conjunctiva
- Eye Diseases
(diagnosis, drug therapy)
- Humans
- Retrospective Studies
- Stevens-Johnson Syndrome
(drug therapy)
|